50 related articles for article (PubMed ID: 7829158)
1. Clinical utility of serum thyroglobulin in metastatic disease.
Shah DH; Kumar A; Vijayan U; Dandekar SR; Krishna BA; Rao RS
Indian J Med Res; 1994 Nov; 100():232-6. PubMed ID: 7829158
[TBL] [Abstract][Full Text] [Related]
2. Detection of thyroglobulin in fine needle aspirates of nonthyroidal neck masses: a clue to the diagnosis of metastatic differentiated thyroid cancer.
Pacini F; Fugazzola L; Lippi F; Ceccarelli C; Centoni R; Miccoli P; Elisei R; Pinchera A
J Clin Endocrinol Metab; 1992 Jun; 74(6):1401-4. PubMed ID: 1592886
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the diagnostic value of the first thyroglobulin determination in detecting metastases after differentiated thyroid carcinoma surgery.
Makarewicz J; Adamczewski Z; Knapska-Kucharska M; Lewiński A
Exp Clin Endocrinol Diabetes; 2006 Oct; 114(9):485-9. PubMed ID: 17115345
[TBL] [Abstract][Full Text] [Related]
4. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma.
Giovanella L; Ceriani L; Suriano S; Ghelfo A; Maffioli M
Clin Endocrinol (Oxf); 2008 Oct; 69(4):659-63. PubMed ID: 18363882
[TBL] [Abstract][Full Text] [Related]
5. Serum thyroglobulin in the investigation of patients presenting with metastases.
Edmonds CJ; Willis CL
Br J Radiol; 1988 Apr; 61(724):317-9. PubMed ID: 3370417
[TBL] [Abstract][Full Text] [Related]
6. Serum thyroglobulin determinations in patients with differentiated thyroid carcinoma.
Bednár J; Nĕmec J; Zamrazil V; Vána S; Pohunková D; Röhling S
Nuklearmedizin; 1983 Aug; 22(4):204-11. PubMed ID: 6634419
[TBL] [Abstract][Full Text] [Related]
7. The usefulness of detecting thyroglobulin in fine-needle aspirates from patients with neck lesions using a sensitive thyroglobulin assay.
Sigstad E; Heilo A; Paus E; Holgersen K; Grøholt KK; Jørgensen LH; Bogsrud TV; Berner A; Bjøro T
Diagn Cytopathol; 2007 Dec; 35(12):761-7. PubMed ID: 18008339
[TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of serum thyroglobulin and antithyroglobulin antibody in differentiated thyroid cancer after thyroid ablation].
Vincze B; Sinkovics I; Keresztes S; Gergye M; Boér A; Remenár E; Péter I; Szentirmay Z; Kremmer T; Kásler M
Magy Onkol; 2004; 48(1):27-34. PubMed ID: 15105893
[TBL] [Abstract][Full Text] [Related]
9. Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma: incidence, causes and management strategy.
Giovanella L; Ceriani L; Ghelfo A; Maffioli M; Keller F
Clin Endocrinol (Oxf); 2007 Oct; 67(4):547-51. PubMed ID: 17561976
[TBL] [Abstract][Full Text] [Related]
10. Serum thyroglobulin in differentiated thyroid carcinoma.
Ericsson UB; Tegler L; Lennquist S; Christensen SB; Ståhl E; Thorell JI
Acta Chir Scand; 1984; 150(5):367-75. PubMed ID: 6485689
[TBL] [Abstract][Full Text] [Related]
11. Serum thyroglobulin differentiated thyroid carcinoma: histological and metastatic classification.
Shah DH; Dandekar SR; Jeevanram RK; Kumar A; Sharma SM; Ganatra RD
Acta Endocrinol (Copenh); 1981 Oct; 98(2):222-6. PubMed ID: 7293654
[TBL] [Abstract][Full Text] [Related]
12. Elevated serum thyroglobulin. A marker of metastases in differentiated thyroid carcinomas.
Herle AJ; Uller RP
J Clin Invest; 1975 Aug; 56(2):272-7. PubMed ID: 1150869
[TBL] [Abstract][Full Text] [Related]
13. Serum thyroglobulin measurements in differentiated thyroid cancer.
Girelli ME; De Vido D
Biomed Pharmacother; 2000 Jul; 54(6):330-3. PubMed ID: 10989968
[TBL] [Abstract][Full Text] [Related]
14. Clinical implication of F-18 FDG PET/CT for differentiated thyroid cancer in patients with negative diagnostic iodine-123 scan and elevated thyroglobulin.
Kim SJ; Lee TH; Kim IJ; Kim YK
Eur J Radiol; 2009 Apr; 70(1):17-24. PubMed ID: 18207685
[TBL] [Abstract][Full Text] [Related]
15. Patients with differentiated thyroid cancer have a venous gradient in thyroglobulin levels.
Kebebew E; Reiff E
Cancer; 2007 Mar; 109(6):1078-81. PubMed ID: 17279579
[TBL] [Abstract][Full Text] [Related]
16. [The value of serum thyroglobulin determination in the after-care of patients with differentiated thyroid neoplasms].
Hüfner M; Pollmann H; Grussendorf M; Schenk P
Schweiz Med Wochenschr; 1980 Feb; 110(5):159-62. PubMed ID: 7361086
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of highly sensitive Tg assay in monitoring patients treated for differentiated thyroid cancer.
Iervasi A; Iervasi G; Ferdeghini M; Solimeo C; Bottoni A; Rossi L; Colato C; Zucchelli GC
Clin Endocrinol (Oxf); 2007 Sep; 67(3):434-41. PubMed ID: 17555505
[TBL] [Abstract][Full Text] [Related]
18. Metastatic medullary and undifferentiated thyroid cancers are not associated with elevated levels of serum thyroglobulin.
Pacini F; Lari R; Taddei D; Grasso L; Martino E; Baschieri L; Pinchera A
Tumori; 1984 Oct; 70(5):417-9. PubMed ID: 6506226
[TBL] [Abstract][Full Text] [Related]
19. High serum thyroglobulin levels. Diagnostic indicators in patients with metastases from unknown primary sites.
Panza N; Lombardi G; De Rosa M; Pacilio G; Lapenta L; Salvatore M
Cancer; 1987 Nov; 60(9):2233-6. PubMed ID: 3440233
[TBL] [Abstract][Full Text] [Related]
20. Serum thyroglobulin levels in patients with bone metastases from an unknown primary site.
Shah DH; Krishna BA; Pradhan SA; Rao RS; Ganatra RD; Sharma SM
Tumori; 1982 Dec; 68(6):481-3. PubMed ID: 7168013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
